Infectious Agents and Cancer

Papers
(The TQCC of Infectious Agents and Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population58
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses40
HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination38
Epidemiology of high-risk human papillomavirus among women of the north-central region of Ecuador: a retrospective study33
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status32
Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors29
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation27
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker27
Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?26
The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review26
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma24
Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China23
Single-cell analysis reveals the regulatory role of ECT2 in HPV-driven cervical carcinogenesis process21
Mendelian randomization in cancer research: opportunities and challenges21
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis21
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients21
Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study21
Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa19
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 19
Precision therapeutic targets for HPV-positive cancers: an overview and new insights19
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer18
Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy17
Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer17
CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression17
Clinical characteristics and prognostic impact of HPV infection in head and neck cancer patients in China: a nationwide multicenter study17
Correction: Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases17
Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa17
Prevalence of HPV in anal cancer: exploring the role of infection and inflammation16
Chlamydia pneumoniae infections and development of lung cancer: systematic review16
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes15
Development and validation of a multiplex qPCR method for identification of high-risk genotypes of human papillomavirus15
Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics14
Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series13
Polygenic risk scores for cervical HPV infection, neoplasia and cancer show potential for personalised screening: comparison of two methods13
The viral origins of breast cancer13
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation13
Multiple pathogens and prostate cancer13
Mandatory preventive vaccines for infectious diseases expressing T-cell epitopes for cancer prevention13
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period13
Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study12
Primary seminal vesicle Burkitt lymphoma in a patient living with HIV undergoing radical prostate and seminal vesicle resection: a rare missed case report12
Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran12
An overview of mouse models of hepatocellular carcinoma12
Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study12
A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR12
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer11
A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma11
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial11
Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case–control study11
Detection of bovine leukemia virus, Epstein-Barr virus and human papillomavirus in breast cancer tissues of Egyptian patients10
Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection10
Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation10
Investigating the expression of HERV-K env, np9, gag, and rec in bladder cancers10
Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review9
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–20179
Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: resu8
Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women8
Microbiota and metabolite profiles of saliva, oral swab and cancer tissue from patients with oral squamous cell carcinoma (OSCC)8
Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study8
Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study8
Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study8
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-38
Incidence of de novo HPV infections in a previous HPV-negative group, related to use of different contraceptive methods: a retrospective cohort study8
Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy7
Seroprevalence of human papilloma virus 6, 11, 16 and 18 among pregnant women in Mwanza-Tanzania7
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance7
Human papillomavirus type 16 and 18 in urothelial bladder neoplasms: detection, quantification, and comparison with non-neoplastic samples7
GYPC methylation performance in detecting cervical (pre)cancer in high-risk HPV-positive women using liquid-based cervical scrapes7
Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites7
Human papillomavirus genotypes in Jeddah, Saudi Arabia: prevalence and public health implications7
Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma7
High-risk human papillomavirus genotyping in cervical cancers in Tanzania7
Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma7
Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma7
High-risk HPV genotypes in women with abnormal cytology: a 12-year retrospective study6
High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia6
Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly6
Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic6
The epidemic of human papillomavirus virus-related oropharyngeal cancer: current controversies and future questions6
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded6
Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection6
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infecti6
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation6
Willingness to accept human papilloma virus vaccination and its associated factors among parents with eligible daughters in Addis Zemen town, Northwest Ethiopia6
0.032351970672607